AOD-9604 Clinical Evidence Context AOD-9604 is unusual among research peptides because it actually completed real Phase 1 and Phase 2 clinical trials
How Cleveland Care Clinic May Use This Option Patient Evaluation Full medical history, labs, comorbid conditions, contraindications screening Informed Consent & Shared Decision Discussion of pros, uncertainties, and monitoring plan Personalized Dosing Plan Titrating dose carefully to balance efficacy and tolerability Comprehensive Support Dietary, behavioral, activity coaching alongside injection therapy Regular Monitoring Tracking metabolic markers, side effects, weight, body composition Adjustment or Transition If compounded therapy is not ideal long-term, transition to FDA-approved alternatives when feasible Who Might Be a Candidate
Ensure compatibility with other supplements
Instead of offering a little bit of everything, the company focuses specifically on sequence-defined research peptides and blends
Explore Peptide Therapy at BEAUX Curious whether BPC-157 is a fit for your goals
Actionable Insight: If youre considering oral supplements, get your levels tested first